Glenview Capital offloads Tenet shares

Glenview Capital Management, an investment firm with more than $3.5 billion in assets, has a 9.99 percent stake in Tenet Healthcare after selling shares of the for-profit provider in April, according to a recent Securities and Exchange Commission filing. 

Advertisement

The investment firm sold 3.08 million shares April 21 and April 22. The shares were sold at prices that ranged from $51.10 to $57.28. Glenview Capital now has 10.65 million shares of Tenet. 

Tenet’s shares closed April 22 at $56.18 per share, up from $54.53 April 21, according to the Dallas-based company. 

More articles on healthcare finance: 
Hospital chain reports late payroll, cash deficiencies
Tenet reports $97M profit in Q1
Hospital adjusted expenses per inpatient day across 50 states

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.